Search Results - "Schapiro, Randall T"

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial by Goodman, Andrew D, Prof, Brown, Theodore R, MD, Krupp, Lauren B, MD, Schapiro, Randall T, MD, Schwid, Steven R, MD, Cohen, Ron, MD, Marinucci, Lawrence N, MS, Blight, Andrew R, PhD

“…Summary Background Clinical studies suggested that fampridine (4-aminopyridine) improves motor function in people with multiple sclerosis. This phase III study…”
Get full text

Managing the Symptoms of Multiple Sclerosis by Schapiro, Randall T

“…This is a fully updated and revised guide to clinically tested and proven methods for effectively managing all of the symptoms characteristic of MS and MS…”
Get full text

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis by Goodman, Andrew D., Brown, Theodore R., Edwards, Keith R., Krupp, Lauren B., Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N., Blight, Andrew R.

“…Objective A previous phase 3 study showed significant improvement in walking ability in multiple sclerosis (MS) patients treated with oral, extended‐release…”
Get full text

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials by Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

“…Background: In Phase 3 double-blind trials (MS-F203 and MS-F204), dalfampridine extended release tablets 10 mg twice daily (dalfampridine-ER; prolonged-release…”
Get full text

Symptoms and physical activity behavior in individuals with multiple sclerosis by Motl, Robert W., Snook, Erin M., Schapiro, Randall T.

“…We examined overall and specific symptoms as correlates of physical activity in individuals with multiple sclerosis (MS). Participants (N = 133) completed…”
Get full text

A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis by Goodman, Andrew D, Brown, Theodore R, Schapiro, Randall T, Klingler, Michael, Cohen, Ron, Blight, Andrew R

“…Two phase 3 clinical trials demonstrated that dalfampridine extended-release 10-mg tablets (D-ER), twice daily, significantly improved walking relative to…”
Get full text

Managing symptoms of multiple sclerosis by Schapiro, Randall T

Get more information

The symptomatic management of multiple sclerosis by Schapiro, Randall T

“…The management of multiple sclerosis (MS) revolves around disease management, symptom management, and person management. Of these, symptom management takes up…”
Get full text

Pharmacologic Options for the Management of Multiple Sclerosis Symptoms by Schapiro, Randall T.

“…Multiple sclerosis (MS) is a disease with a wide-ranging impact on physical functioning. Although pharmacotherapy plays an indispensable role in the management…”
Get full text

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis by Schapiro, R T

“…Multiple sclerosis (MS) is a disease with tremendous variability and innumerable symptoms. Among the more common symptoms is spasticity. Despite a lack of full…”
Get full text

Managing the symptoms of multiple sclerosis, sixth edition by Schapiro, Randall T

Get full text

Current and future directions in MS management: key considerations for managed care pharmacists by Lipsy, Robert J, Schapiro, Randall T, Prostko, Chris R

“…The management paradigm for multiple sclerosis (MS) continues to evolve and is shifting toward earlier diagnosis, differentiation of patients with varying…”
Get full text

Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis by Di Fabio, R P, Soderberg, J, Choi, T, Hansen, C R, Schapiro, R T

“…To determine the influence of an extended outpatient rehabilitation program on symptom frequency, fatigue, and functional status for persons with multiple…”
Get more information

Neurological Impairment as Confounder or Moderater of Association Between Symptoms and Physical Activity in Multiple Sclerosis by Motl, Robert W., Snook, Erin M., Schapiro, Randall T.

“…The article examines neurological impairment as a possible confounding and moderating influence of the association between symptoms and physical-activity…”
Get full text

Part IV: Appendices by Schapiro, Randall T

Get full text

Part I: The Disease and Its Management by Schapiro, Randall T

Get full text

Patr III: Your Total Health by Schapiro, Randall T

Get full text

Share Managing the Symptoms of Multiple Sclerosis, Sixth Edition by Schapiro, Randall T

Get full text

Part II: Managing the Symptoms of Multiple Sclerosis by Schapiro, Randall T

Get full text

Symptom management in multiple sclerosis by Schapiro, R T

“…Presently, the course of multiple sclerosis (MS) can be altered little, if at all. Appropriate symptom management, however, can change the course of lives and…”
Get more information